Risk management advisory committee plays it safe
Executive Summary
FDA postpones Drug Safety & Risk Management Advisory Committee Sept. 18 and 19 meeting as a result of Hurricane Isabel. Committee was slated to discuss labeling and packaging of drug products in low-density polyethylene plastic vials Sept. 18 and screening methods for look-alike, sound-alike proprietary drug names Sept. 19 (1"The Pink Sheet" June 29, 2003, In Brief)...